Progyny, Inc. PGNY
Set alert
29.19 USD +0.79 +2.78%
At close · Oct 30
29.19 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
28.35 Day range 29.22
16.10 52-week range 33.07
- YTD
- +13.67%
- 1 year
- +56.51%
- Open
- 28.66
- Prev close
- 28.40
- Mkt cap
- 2.24B
- Vol
- 807.73K
- Avg vol
- 1.10M
- EPS
- 0.92
- P/E
- 31.73
- Div yield
- 0.00%
More statistics
- Low
- 28.35
- High
- 29.22
- Forward P/E
- 12.62
- Beta
- 1.02
- Short ratio
- 4.06
- Inst. own
- 108.07%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 26.81
- 200-d avg
- 24.34
- 1y target
- 34.42
5Y chart
Events in this range
- Aug 7, 2025Earnings: 0.2; estimate 0.17; surprise 17.65%
- Nov 6, 2025Earnings: 0.16; estimate 0.39; surprise -58.97%
- Feb 26, 2026Earnings: 0.15; estimate 0.147; surprise 2.04%
- May 7, 2026Earnings: 0.3; estimate 0.256; surprise 17.19%
- Aug 6, 2026Earnings: 0.36; estimate 0.3348; surprise 7.53%
- Aug 12, 2026Rating: Barclays · Equal-Weight → Equal-Weight
- Aug 13, 2026Rating: Truist Securities · Buy → Buy
- Aug 20, 2026Rating: Wells Fargo · — → Overweight
- Aug 21, 2026Rating: JP Morgan · Neutral → Neutral
- Sep 8, 2026Rating: Citizens · Market Outperform → Market Outperform
- Sep 30, 2026Rating: Wells Fargo · — → Overweight
- Nov 4, 2026Earnings: —; estimate 0.313; surprise —%
Signals (88)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 5, 2026 | 4 weeks ago |
| MACD: Sell Signal | Aug 17, 2026 | 2 months ago |
| SMA: Bearish | Aug 3, 2026 | 3 months ago |
| RSI: Overbought | Jun 29, 2026 | 4 months ago |
| SMA: Bullish | May 4, 2026 | 6 months ago |
| MACD: Buy Signal | May 4, 2026 | 6 months ago |
| SMA: Bullish | Apr 20, 2026 | 6 months ago |
| SMA: Bearish | Feb 2, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 26, 2026 | 9 months ago |
| SMA: Bearish | Jan 12, 2026 | 9 months ago |
| MACD: Buy Signal | Nov 10, 2025 | 11 months ago |
| SMA: Bullish | Nov 3, 2025 | 12 months ago |
| SMA: Bullish | Nov 3, 2025 | 12 months ago |
| SMA: Bearish | Sep 15, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 15, 2025 | 1 year ago |
| SMA: Bearish | Sep 1, 2025 | 1 year ago |
| SMA: Bullish | Jul 7, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 7, 2025 | 1 year ago |
| SMA: Bearish | Jun 30, 2025 | 1 year ago |
| SMA: Bullish | Jun 23, 2025 | 1 year ago |
| MACD: Sell Signal | May 26, 2025 | 1 year ago |
| SMA: Bearish | May 19, 2025 | 1 year ago |
| SMA: Bullish | May 12, 2025 | 1 year ago |
| SMA: Bearish | May 5, 2025 | 1 year ago |
| SMA: Bullish | Apr 21, 2025 | 1 year ago |
| SMA: Bearish | Apr 14, 2025 | 1 year ago |
| SMA: Bullish | Mar 31, 2025 | 1 year ago |
| SMA: Bearish | Mar 3, 2025 | 1 year ago |
| SMA: Bullish | Jan 13, 2025 | 1 year ago |
| SMA: Bullish | Dec 23, 2024 | 1 year ago |
| MACD: Buy Signal | Nov 25, 2024 | 1 year ago |
| RSI: Oversold | Nov 11, 2024 | 1 year ago |
| RSI: Oversold | Oct 21, 2024 | 2 years ago |
| RSI: Oversold | Sep 16, 2024 | 2 years ago |
| MACD: Sell Signal | Aug 5, 2024 | 2 years ago |
| RSI: Oversold | Aug 5, 2024 | 2 years ago |
| SMA: Bearish | Jul 29, 2024 | 2 years ago |
| MACD: Buy Signal | Jul 22, 2024 | 2 years ago |
| SMA: Bullish | Jun 24, 2024 | 2 years ago |
| SMA: Bearish | Apr 1, 2024 | 2 years ago |
| SMA: Bearish | Apr 1, 2024 | 2 years ago |
| SMA: Bullish | Mar 25, 2024 | 2 years ago |
| SMA: Bullish | Mar 18, 2024 | 2 years ago |
| SMA: Bearish | Mar 4, 2024 | 2 years ago |
| MACD: Sell Signal | Mar 4, 2024 | 2 years ago |
| SMA: Bearish | Feb 26, 2024 | 2 years ago |
| SMA: Bullish | Dec 18, 2023 | 2 years ago |
| SMA: Bearish | Dec 11, 2023 | 2 years ago |
| SMA: Bullish | Dec 4, 2023 | 2 years ago |
| MACD: Buy Signal | Dec 4, 2023 | 2 years ago |
| SMA: Bullish | Nov 20, 2023 | 2 years ago |
| SMA: Bearish | Sep 11, 2023 | 3 years ago |
| MACD: Sell Signal | Aug 21, 2023 | 3 years ago |
| SMA: Bearish | Aug 7, 2023 | 3 years ago |
| SMA: Bullish | Jul 10, 2023 | 3 years ago |
| SMA: Bearish | Jul 3, 2023 | 3 years ago |
| SMA: Bullish | Jun 26, 2023 | 3 years ago |
| SMA: Bearish | Jun 19, 2023 | 3 years ago |
| SMA: Bullish | May 1, 2023 | 3 years ago |
| SMA: Bearish | Apr 24, 2023 | 3 years ago |
| SMA: Bullish | Apr 17, 2023 | 3 years ago |
| SMA: Bullish | Apr 17, 2023 | 3 years ago |
| SMA: Bearish | Mar 27, 2023 | 3 years ago |
| SMA: Bullish | Mar 20, 2023 | 3 years ago |
| SMA: Bearish | Mar 6, 2023 | 3 years ago |
| SMA: Bearish | Mar 6, 2023 | 3 years ago |
| SMA: Bullish | Feb 27, 2023 | 3 years ago |
| SMA: Bullish | Feb 27, 2023 | 3 years ago |
| SMA: Bearish | Feb 20, 2023 | 3 years ago |
| SMA: Bullish | Feb 13, 2023 | 3 years ago |
| SMA: Bearish | Feb 6, 2023 | 3 years ago |
| MACD: Buy Signal | Jan 30, 2023 | 3 years ago |
| SMA: Bullish | Jan 9, 2023 | 3 years ago |
| MACD: Sell Signal | Nov 21, 2022 | 3 years ago |
| SMA: Bearish | Nov 14, 2022 | 3 years ago |
| SMA: Bearish | Nov 7, 2022 | 3 years ago |
| SMA: Bullish | Oct 24, 2022 | 4 years ago |
| SMA: Bullish | Oct 17, 2022 | 4 years ago |
| SMA: Bearish | Sep 19, 2022 | 4 years ago |
| SMA: Bearish | Sep 19, 2022 | 4 years ago |
| SMA: Bullish | Sep 5, 2022 | 4 years ago |
| SMA: Bearish | Aug 29, 2022 | 4 years ago |
| SMA: Bullish | Aug 1, 2022 | 4 years ago |
| MACD: Buy Signal | Jul 25, 2022 | 4 years ago |
| SMA: Bullish | Jul 18, 2022 | 4 years ago |
| RSI: Oversold | May 16, 2022 | 4 years ago |
| SMA: Bearish | Apr 11, 2022 | 4 years ago |
| SMA: Bullish | Feb 28, 2022 | 4 years ago |
Key statistics
- Market cap
- 2.24B
- Enterprise value
- 1.97B
- Trailing P/E
- 31.73
- Forward P/E
- 12.62
- PEG ratio
- 0.00
- Price / sales
- 1.71
- Price / book
- 4.94
- EPS (TTM)
- 0.92
- Beta
- 1.02
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 6.00%
- Revenue (TTM)
- 1.31B
- Revenue growth
- 5.30%
- Free cash flow
- 196.47M
- Total cash
- 236.92M
- Total debt
- 26.97M
- Return on equity
- 16.24%
- Shares outstanding
- 76.73M
- Short % of float
- 8.93%
- 50-day average
- 26.81
- 200-day average
- 24.34
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 34.42 +17.9% upside
Now 29.19
- Target (low)
- 30.00
- Target (mean)
- 34.42
- Target (high)
- 40.00
Ratings (0m) 12 10 buy · 2 hold · 0 sell
- Strong buy1
- Buy9
- Hold2
- Sell0
- Strong sell0
Next earnings
Nov 4, 2026
Expected Nov 4, 2026. Consensus EPS estimate 0.50894.
Financials — quick view
PGNY Revenue — quarterly 350.51M
PGNY Net income — quarterly 28.05M
PGNY EPS — quarterly 0.36
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 4, 2026 | Sep 30, 2026 | 0.313 | — | — | — |
| Aug 6, 2026 | Jun 30, 2026 | 0.3348 | 0.36 | +0.03 | +7.53% |
| May 7, 2026 | Mar 31, 2026 | 0.256 | 0.30 | +0.04 | +17.19% |
| Feb 26, 2026 | Dec 31, 2025 | 0.147 | 0.15 | 0.00 | +2.04% |
| Nov 6, 2025 | Sep 30, 2025 | 0.39 | 0.16 | -0.23 | -58.97% |
| Aug 7, 2025 | Jun 30, 2025 | 0.17 | 0.20 | +0.03 | +17.65% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 30, 2026 | Wells Fargo | init | — | Overweight |
| Sep 8, 2026 | Citizens | main | Market Outperform | Market Outperform |
| Aug 21, 2026 | JP Morgan | main | Neutral | Neutral |
| Aug 20, 2026 | Wells Fargo | init | — | Overweight |
| Aug 13, 2026 | Truist Securities | main | Buy | Buy |
| Aug 12, 2026 | Barclays | main | Equal-Weight | Equal-Weight |
About Progyny, Inc.
Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services, as well as pregnancy and postpartum, menopause and midlife, benefit and leave navigation, and parent and child wellbeing solutions. In addition, it provides assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
- Sector
- Healthcare
- Industry
- Healthcare Plans
- Country
- United States
- Website
- progyny.com
News
- New Progyny Study Examines Persistent Racial and Ethnic Differences in Fertility Treatment Initiation Despite Access to Benefits
- New Progyny Study Finds Significant Improvement in Menopause Symptoms Through Connected Care Model
- Progyny, Inc. Announces Details for Its Third Quarter 2026 Results Report
- Progyny (NASDAQ:PGNY) COO Sells $52,612.00 in Stock
- Progyny to Present New Menopause Research at The Menopause Society 2026 Annual Meeting
- Progyny (PGNY) Soars 6.3%: Is Further Upside Left in the Stock?
- PGNY or CRL: Which Is the Better Value Stock Right Now?
- Progyny, Inc. Selling Season Pacing to Record Level, Revealing Critical Insights on Latest Market Dynamics
- PGNY vs. CRL: Which Stock Is the Better Value Option?
- Progyny: Best-In-Class And Likely To Exceed Analyst Estimates In 2027
Your note
Sign in to keep a note on PGNY — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ANEVSKI PETER | Chief Executive Officer | Stock Award(Grant) | Mar 1, 2026 | 816,834 |
| CLAPP GEOFFREY | Officer | Conversion of Exercise of derivative security | Jun 1, 2026 | 60,647 |
| CUMMINGS MELISSA B | Chief Operating Officer | Sale | Jul 13, 2026 | 69,934 |
| DEAN LLOYD H | Director | Stock Award(Grant) | May 20, 2026 | 26,519 |
| HOLSTEIN ROGER C | Director | Stock Award(Grant) | May 20, 2026 | 28,729 |
| LIVINGSTON MARK S | Chief Financial Officer | Sale | Jun 3, 2026 | 74,688 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 15.12% | 11,599,921 | 338.60M | Jun 29, 2026 |
| FMR, LLC | 9.13% | 7,004,280 | 204.45M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 6.54% | 5,019,465 | 146.52M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.18% | 3,210,723 | 93.72M | Jun 29, 2026 |
| State Street Corporation | 3.94% | 3,022,859 | 88.24M | Jun 29, 2026 |
| Ameriprise Financial, Inc. | 3.60% | 2,763,514 | 80.67M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Small-Cap ETF | 5.95% | 4,566,776 | 133.30M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.92% | 2,242,829 | 65.47M | Jun 29, 2026 |
| Touchstone Strategic TRT-Touchstone Strategic TRT-Touchstone Small Com | 2.53% | 1,940,666 | 56.65M | Jun 29, 2026 |
| American Century ETF Trust-Avantis U.S. Small Cap Value ETF | 2.51% | 1,928,807 | 56.30M | Sep 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.48% | 1,902,275 | 55.53M | Sep 29, 2026 |
| Fidelity Securities Fund-Fidelity Small Cap Growth Fund | 2.18% | 1,676,019 | 48.92M | Jul 30, 2026 |